<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "lopinavir-ritonavir liq ORAL">
<dose><value>5</value>
<value>10</value>
<value>12</value>
<value>230/57.5</value>
<value>13</value>
<value>11</value>
<value>300/75</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>80 mg-20 mg/mL</value>
</strength>
<frequency><value>BID</value>
<value>DAILY</value>
</frequency>
<instruction></instruction>
<volume><value>160 mL</value>
</volume>
<units><value>mL</value>
<value>mg/kg</value>
<value>mg/m2</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Patients weighing from 7 to less than 15 kg, without concomitant efavirenz, nevirapine, nelfinavir or amprenavir.</value>
<value>Patients weighing from 15 kg to 40 kg, without concomitant efavirenz, nevirapine, nelfinavir or amprenavir.</value>
<value>Patients not receiving concomitant efavirenz, nevirapine, nelfinavir or amprenavir.</value>
<value>Patients weighing from 7 to less than 15 kg, with concomitant efavirenz, nevirapine, nelfinavir or amprenavir.</value>
<value>Patients weighing from 15 kg to 45 kg, with concomitant efavirenz, nevirapine, nelfinavir or amprenavir.</value>
<value>Patients receiving concomitant efavirenz, nevirapine, nelfinavir or amprenavir.</value>
</AdditionalNotes>
<BackgroundInformation><value>Dosing based upon lopinavir component</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Antivirals, Antiretrovirals</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>